Mineralocorticoid regulation of cyclooxygenase-2 expression in rat renal medulla.
The renal inner medulla and its distal one-third, the papilla, are major sites of prostanoid synthesis involved in water and electrolyte homeostasis. These sites contain variable levels of cyclooxygenase (COX)-2, a key prostaglandin synthase enzyme that is sensitive to adrenal steroids. Immunoreactive renal medullary COX-2, restricted to interstitial cells in control adult rats, shows a gradient of intense staining at the tip of the papilla that gradually diminishes to undetectable levels in the proximal inner medulla. We used adrenalectomy (ADX) and steroid replacement to investigate the effects of steroids on papillary COX-2. Immunoblots demonstrate that papillary COX-2 was reduced by one-half after 2 wk ADX; glucocorticoid replacement ameliorated the decline but not to control levels. Mineralocorticoid (deoxycorticosterone acetate; DOCA) replacement stimulated papillary COX-2 more than fivefold over control; both the intensity of immunostaining and the numbers of COX-2-positive cells in the inner medulla increased. Similar stimulation of papillary COX-2 resulted from DOCA treatment of normal control rats, but the response was blunted in rats fed a low-salt diet and absent in Brattleboro rats. DOCA treatment of mouse renal medullary interstitial cells in culture had no effect, but increased tonicity of the culture medium with NaCl caused strong upregulation of COX-2. Urea, a permeant molecule, had no effect. Together, these results suggest that mineralocorticoids lead to upregulation of COX-2 in rat renal medulla by indirect pathways, probably involving induced electrolyte hypertonicity in the interstitial fluid.
Zhang
Ming-Zhi
MZ
George O'Brien Center for Kidney and Urologic Diseases, Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
Hao
Chuan-Ming
CM
Breyer
Matthew D
MD
Harris
Raymond C
RC
McKanna
James A
JA
D000315:Adrenalectomy; D000818:Animals; D015153:Blotting, Western; D002478:Cells, Cultured; D051546:Cyclooxygenase 2; D003900:Desoxycorticosterone / Q000494:pharmacology; D003919:Diabetes Insipidus / Q000201:enzymology; D004847:Epithelial Cells / Q000201:enzymology; D005260:Female; D006706:Homeostasis; D007527:Isoenzymes / Q000378:metabolism*; D007679:Kidney Medulla / Q000201:enzymology*; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists; D008901:Mineralocorticoids / Q000494:pharmacology*; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism*; D051381:Rats; D011910:Rats, Brattleboro; D017207:Rats, Sprague-Dawley; D011965:Receptors, Glucocorticoid / Q000037:antagonists & inhibitors / Q000502:physiology; D018161:Receptors, Mineralocorticoid / Q000502:physiology; D013148:Spironolactone / Q000494:pharmacology
D007527:Isoenzymes; D000451:Mineralocorticoid Receptor Antagonists; D008901:Mineralocorticoids; D011965:Receptors, Glucocorticoid; D018161:Receptors, Mineralocorticoid; D013148:Spironolactone; D003900:Desoxycorticosterone; D051546:Cyclooxygenase 2; D011451:Prostaglandin-Endoperoxide Synthases